Cargando…

Drugs to the Rescue: Comparison of On-Demand Therapies for OFF Symptoms in Parkinson’s Disease

Patients with Parkinson’s disease often suffer from OFF symptoms disrupting their daily routines and adding to disabilities. Despite polypharmacy and adjustments to medication schedules, they often do not experience consistent relief from their motor symptoms. As the disease progresses, impaired gas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martinez-Nunez, Alfonso E., LeWitt, Peter A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357202/ https://www.ncbi.nlm.nih.gov/pubmed/37182902 http://dx.doi.org/10.3233/JPD-230055

Ejemplares similares

Norepinephrine: the next therapeutics frontier for Parkinson's disease
por: LeWitt, Peter A
Publicado: (2012)

Clinical Use of On-Demand Therapies for Patients with Parkinson’s Disease and OFF Periods
por: Pahwa, Rajesh, et al.
Publicado: (2023)

Parkinson Disease and Orthostatic Hypotension in the Elderly: Recognition and Management of Risk Factors for Falls
por: LeWitt, Peter A, et al.
Publicado: (2019)

Application of Neuromelanin MR Imaging in Parkinson Disease
por: He, Naying, et al.
Publicado: (2022)

Caloric vestibular stimulation for the management of motor and non-motor symptoms in parkinson's disease: Intention-to-treat data
por: Wilkinson, David, et al.
Publicado: (2019)

Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson’s disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER
por: LeWitt, Peter A., et al.
Publicado: (2012)

What Have We Learned from Cerebrospinal Fluid Studies about Biomarkers for Detecting LRRK2 Parkinson’s Disease Patients and Healthy Subjects with Parkinson’s-Associated LRRK2 Mutations?
por: Loeffler, David A., et al.
Publicado: (2019)

Pulmonary Safety and Tolerability of Inhaled Levodopa (CVT-301) Administered to Patients with Parkinson's Disease
por: LeWitt, Peter A., et al.
Publicado: (2018)

Should “on-demand” treatments for Parkinson’s disease OFF episodes be used earlier?
por: Isaacson, Stuart H., et al.
Publicado: (2022)

Adjuvant medical therapy in cervical dystonia after deep brain stimulation: A retrospective analysis
por: Martinez-Nunez, Alfonso E., et al.
Publicado: (2022)

Non-Motor Off Symptoms in Parkinson's Disease
por: Cheon, Sang-Myung, et al.
Publicado: (2009)

Cellular immune response to intrastriatally implanted allogeneic bone marrow stromal cells in a rat model of Parkinson's disease
por: Camp, Dianne M, et al.
Publicado: (2009)

The Efficacy Profile of Rotigotine During the Waking Hours in Patients With Advanced Parkinson's Disease: A Post Hoc Analysis
por: LeWitt, Peter A., et al.
Publicado: (2016)

Increased Oxidative Stress Markers in Cerebrospinal Fluid from Healthy Subjects with Parkinson’s Disease-Associated LRRK2 Gene Mutations
por: Loeffler, David A., et al.
Publicado: (2017)

Effect of Concomitant Medications on the Safety and Efficacy of Extended-Release Carbidopa-Levodopa (IPX066) in Patients With Advanced Parkinson Disease: A Post Hoc Analysis
por: LeWitt, Peter A., et al.
Publicado: (2018)

Cost-Effectiveness of Apomorphine Sublingual Film as an “On-Demand” Treatment for “OFF” Episodes in Patients with Parkinson’s Disease
por: Thach, Andrew, et al.
Publicado: (2021)

Opicapone Pharmacokinetics and Effects on Catechol-O-Methyltransferase Activity and Levodopa Pharmacokinetics in Patients With Parkinson Disease Receiving Carbidopa/Levodopa
por: LeWitt, Peter, et al.
Publicado: (2023)

Expert Consensus on the Use of On‐Demand Treatments for OFF Episodes in Parkinson's Disease: A Modified Delphi Panel
por: Isaacson, Stuart H., et al.
Publicado: (2023)

Parkinson's disease motor symptoms rescue by CRISPRa‐reprogramming astrocytes into GABAergic neurons
por: Giehrl‐Schwab, Jessica, et al.
Publicado: (2022)

Efficacy of Istradefylline, an Adenosine A(2A) Receptor Antagonist, as Adjunctive Therapy to Levodopa in Parkinson’s Disease: A Pooled Analysis of 8 Phase 2b/3 Trials
por: Hauser, Robert A., et al.
Publicado: (2021)

Pupillary Response to Postural Demand in Parkinson’s Disease
por: Kahya, Melike, et al.
Publicado: (2021)

Management of OFF condition in Parkinson disease
por: Koch, Jessa
Publicado: (2023)

Slurring of Speech and Lip Paresthesia: Symptoms of Levodopa End of Dose Wearing Off in Parkinson's Disease
por: Nasir, Usama, et al.
Publicado: (2018)

Why do ‘OFF’ periods still occur during continuous drug delivery in Parkinson’s disease?
por: Rota, Silvia, et al.
Publicado: (2022)

Reliability and Validity of Fall Efficacy Scale-International in People with Parkinson's Disease during On- and Off-Drug Phases
por: Mehdizadeh, Maryam, et al.
Publicado: (2019)

Wearing-off in Parkinson’s disease: neuropsychological differences between on and off periods
por: Caillava-Santos, Fabiane, et al.
Publicado: (2015)

Anesthesiologist to surgeons’ rescue: An off label use of choledochoscope
por: Aggarwal, Shiba, et al.
Publicado: (2012)

Off-time Treatment Options for Parkinson’s Disease
por: Fabbri, Margherita, et al.
Publicado: (2023)

Metformin rescues Parkinson’s disease phenotypes caused by hyperactive mitochondria
por: Mor, Danielle E., et al.
Publicado: (2020)

Drug therapy in patients with Parkinson’s disease
por: Müller, Thomas
Publicado: (2012)

The Impact of Living with Parkinson's Disease: Balancing within a Web of Needs and Demands
por: Sjödahl Hammarlund, Catharina, et al.
Publicado: (2018)

Frequency and Dynamics of Non-motor Symptoms Presentation in Hispanic Patients With Parkinson Disease
por: Sánchez-Martínez, Claudia Marisol, et al.
Publicado: (2019)

Beta burst dynamics in Parkinson’s disease OFF and ON dopaminergic medication
por: Tinkhauser, Gerd, et al.
Publicado: (2017)

Validating the Vietnamese version of wearing – Off 19 questionnaire for patients with Parkinson's disease
por: Ha, Uyen Le Ngoc, et al.
Publicado: (2019)

Comparison of Laboratory and Daily-Life Gait Speed Assessment during ON and OFF States in Parkinson’s Disease
por: Corrà, Marta Francisca, et al.
Publicado: (2021)

Perforating lichen nitidus
por: LeWitt, Tessa, et al.
Publicado: (2020)

Pupillary Response to Cognitive Demand in Parkinson’s Disease: A Pilot Study
por: Kahya, Melike, et al.
Publicado: (2018)

Double-Tap Interaction as an Actuation Mechanism for On-Demand Cueing in Parkinson’s Disease
por: Sweeney, Dean, et al.
Publicado: (2019)

Clinimetrics of the Freezing of Gait Questionnaire for Parkinson Disease During the “off” State
por: Taghizadeh, Ghorban, et al.
Publicado: (2021)

Movement Speed-Accuracy Trade-Off in Parkinson's Disease
por: Fernandez, Laure, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jvmuapb7187f3mkvrgi7l7fvfp